This HTML5 document contains 12 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

PrefixNamespace IRI
dbpedia-owlhttp://dbpedia.org/ontology/
foafhttp://xmlns.com/foaf/0.1/
rdfshttp://www.w3.org/2000/01/rdf-schema#
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n6http://commons.wikimedia.org/wiki/Special:FilePath/Zanamivir_structure.svg?width=
xsdhhttp://www.w3.org/2001/XMLSchema#
dbpediahttp://dbpedia.org/resource/
n4http://commons.wikimedia.org/wiki/Special:FilePath/Zanamivir_structure.
Subject Item
dbpedia:Zanamivir
rdfs:comment
Zanamivir INN /zəˈnæmɨvɪər/ is a neuraminidase inhibitor used in the treatment and prophylaxis of influenza caused by influenza A and B viruses. It was developed by the Australian biotech firm Biota Holdings. It was licensed to Glaxo in 1990 and approved in the US in 1999, only for use as a treatment for influenza. In 2006, it was approved for prevention of influenza A and B. Zanamivir was the first neuraminidase inhibitor commercially developed.
foaf:depiction
n4:svg
dbpedia-owl:atcPrefix
J05
dbpedia-owl:atcSuffix
AH01
dbpedia-owl:bioavailability
2.0
dbpedia-owl:casNumber
139110-80-8
dbpedia-owl:chEBI
50663
dbpedia-owl:drugbank
DB00558
dbpedia-owl:fdaUniiCode
L6O3XI777I
dbpedia-owl:iupacName
(2R,3R,4S)-4-guanidino-3-(prop-1-en-2-ylamino)-2-((1R,2R)-1,2,3-trihydroxypropyl)-3,4-dihydro-2H-pyran-6-carboxylic acid
dbpedia-owl:pubchem
60855
dbpedia-owl:thumbnail
n6:300